Timothy Stanley: Doctor lespater, there's a really interesting story playing out in the equity market right now. You have shares of madurna under pressure, down 12 % on this news. Do you think that fewer people will get vaccinated, because that's part of the thesis as to why maderna shares are down? He says i don't think so. Maderna ath moran technology is not just for cob and may be useful for ritin cancers, other viruses. So i think it's probably an overly action on both stocks, quite frankly.
Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, discusses Merck's Covid drug reportedly reducing hospitalization and deaths. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Atlanta Bureau Chief Brett Pulley share Brett's Businessweek Magazine story Atlanta’s Wealthiest and Whitest District Wants to Secede. Bloomberg News Digital News Executive Editor Joe Weisenthal explains how the trillion-dollar coin avoids a constitutional crisis. Juthica Chou, Head of OTC Options Trading at Kraken, talks about Bitcoin volatility. And we Drive to the Close with Anu Gaggar, Global Investment Strategist at Commonwealth Financial Network.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.